Helicobacter pylori: Microbiology and interactions with gastrointestinal microflora

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 3, 2006, Pages 5-14

  Dzierzanowska Fangrat, Katarzyna ^a   Dzierzanowska, D ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Helicobacter pylori; Microflora; Probiotics; Virulence

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; GINGER EXTRACT; LEVOFLOXACIN; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; PLANT EXTRACT; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; ROXITHROMYCIN; TETRACYCLINE; TINIDAZOLE; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CROSS RESISTANCE; DISEASE COURSE; DRUG POTENTIATION; DRUG SENSITIVITY; ENVIRONMENTAL FACTOR; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; NONHUMAN; PATIENT COMPLIANCE; PEPTIC ULCER; POLAND; RESPIRATORY TRACT INFECTION; STOMACH BIOPSY; TREATMENT FAILURE;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; POLAND; PROBIOTICS; VIRULENCE;

EID: 33750288331     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186.
2. Parsonnent J. H. pylori - the size of the problem. Gut 1998; 43 (suppl 1): 3247-3249.
3. National Institutes of Health Concensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development panel on Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-69.
4. Megraud F. Helicobacter pylori antibiotics resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-1384.
5. Hawtin PR, Stacey AR, Newell DG. Investigation of the structure and location of the urease of Helicobacter pylori using monoclonal antibodies. J Gen Microbiol 1990; 136: 1995-2000.
6. Rektorscheck M, Weeks D, Sachs G, Melchers K. Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology 1998; 115: 628-641.
7. Hazell SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986; 153: 658-663.
8. Slomiany BL, Murty VLN, Piotrowski J, Liau YH, Sundaram P, Slomiany A. Glycosulfatase activity of Helicobacter pylori toward gastric mucin. Biochem Biophys Res Comm 1992; 183: 506-513.
9. Langton SR, Cesareo SD. Helicobacter pylori associated phospholipase A2 activity: a factor in peptic ulcer production? J Clin Pathol 1992; 45: 221-224.
10. Spigelhalder CB, Gerstenecker A, Kersten, Schiltz E, Kist M. Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene. Infect Immun 1993; 61: 5315-5325.
11. Hazell SL, Evans DJ Jr, Graham DY. Helicobacter pylori catalase. J Gen Microbiol 1991; 137: 57-61.
12. Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279: 373-377.
13. Jung HC, Kim JM, Song IS, Kim CY. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumor necrosis factor alpha. J Gastroenterol Hepatol 1997; 12: 473-480.
14. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001; 96: 16-26.
15. Beswick EJ, Bland DA, Suarez G, Barrera CA, Fan X, Reyes VE. Helicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 production. Infect Immun 2005; 73: 2736-2743.
16. Censini S, Lange N, Xiang Z, et al. Cag, a pathogenecity island of Helicobacter pylori encodes Type-I-specific and disease associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-14653.
17. Atherton JC, Cao P, Peek RMJ, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating toxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777.
18. Gerhard M, Lehn N, Neumayer N, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A 1999; 96: 12778-12783.
19. Megraud F. Impact of Helicobacter pylori virulence on the outcome of gastroduodenal diseases: lessons from the microbiologist. Dig Dis 2001; 19: 99-103.
20. Blaser MJ, Berg DE. H. pylori genetic diversity and risk of human disease. J Clin Invest 2001; 107: 767-773.
21. Nogueira C, Figueiredo C, Carneiro F, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001; 158: 647-654.
22. Atherton JC, Tham KT, Peek RMJ, Cover TL, Blaser MJ. Density of Helicobacter pylori infection in vivo as assesed by quantitative culture and histology. J Infect Dis 1996; 174: 552-556.
23. Dzierżanowska-Fangrat K, Crabtree JE, Rożynek E, et al. Helicobacter pylori cagA genotype and density of colonization in relation to gastric inflammation in children. Eur J Gastroenterol Hepatol 2002; 14: 1303-1307.
24. Israel DA, Peek RM. Pathogenesis of Helicobacter pylori - induced gastric inflammation. Aliment Pharmacol Ther 2001; 15: 1271-1290.
25. Gzyl A, Augustynowicz E, Dzierżanowska D, et al. Genotypes of Helicobacter pylori in Polish population. Acta Microbiol Pol 1999; 48: 261-275.
26. Chan WY, Hui PK, Leung KM, Chow J, Kwok F, Ng CS. Coccoid forms of Helicobacter pylori in the human stomach. Am J Clin Pathol 1994; 102: 503-507.
27. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston. Am J Surg Pathol 1994; 20: 1161-1181.
28. Hua J, Yeoh KG, Ng HC, et al. Improving the success of culturing Helicobacter pylori from gastric biopsies. Microbios 1998; 96: 95-101.
29. Cellini L, Allocati N, Piatelli A, Petrelli I, Fanci P, Dainelli B. Microbiological evidence of Helicobacter pylori from dental plaque in dyspeptic patients. New Microbiol 1995; 18: 187-192.
30. Thomas JE, Gibson GR, Darboe MK, Dale A, Weaver LT. Isolation of Helicobacter pylori from human faeces. Lancet 1992; 340: 1194-1195.
31. Paull G, Yardley JH. Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus. Gastroenterology 1988; 95: 216-18.
32. Queiroz DMM, Santos A, Oliveira AG, et al. Isolation of a Helicobacter strain from the human liver. Gastroenterology 2001; 121: 1023-1024.
33. Fox JG, Dewhirst FE, Shen Z, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998; 114: 755-763.
34. Nilsson H-O, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 39: 1072-1076.
35. Kowalski M, Rees W, Konturek PC, et al. Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 2002; 34: 398-402.
36. Megraud F, Lehn N, Lind T, et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 Study. Antimicrob Agents Chemother 1999; 43: 2747-2752.
37. Dzierżanowska-Fangrat K, Rożynek E, Celiñska-Cedro D, et al. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study. Int J Antimicrob Agents 2005; 26: 230-234.
38. Adamsson I, Nord CE, Lundquist P, Sjostest S, Edlund C. Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 1999; 44: 629-640.
39. Sjolund M, Wreiber K, Andersson DI, Blaser MJ, Engstrand L. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med 2003; 139: 483-487.
40. Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995; 79: 475-479.
41. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31: 1231-1233.
42. Kabir AMA, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997; 41: 49-55.
43. Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol 2002; 32: 105-110.
44. Mrda Z, Zivanovic M, Rasic J, et al. Therapy of Helicobacter pylori infection using Lactobacillus acidophilus. Med Pregl 1998; 51: 343-345.
45. Sakamoto I, Igarashi M, Kimura K, Takagi AQ, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001; 47: 709-710.
46. Bazzoli F, Zagari RM, Fossi S, et al. In vivo Helicobacter pylori clearance failure with Lactobacillus acidophilus. Gastroenterology 1992; 102: A38.
47. Cruchet S, Obregon MC, Salazar G, Diaz E, Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 2003; 19: 716-721.
48. Sheu BS, Wu JJ, Lo CY, et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16: 1669-1675.
49. Sykora J, Valeckova K, Amlerova J, et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005; 39: 692-698.
50. Myllyluoma E, Veijola L, Ahlroos T, et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy- a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther 2005; 21: 1263-1272.
51. Madden JAJ, Plummer SF, Tang J, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol 2005; 5: 1091-1097.
52. Hiramoto S, Itoh K, Shizuuchi S, et al. Melanoidin, a food protein-derived advanced Maillard reaction product, supresses Helicobacter pylori in vitro and in vivo. Helicobacter 2004; 9: 429-435.
53. O'Mahony R, Al-Khtheeri H, Weerasekera D, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol 2005; 11: 7499-7507.